134 related articles for article (PubMed ID: 30369774)
1. Cyclin E and FGF8 are downstream cell growth regulators in distinct tumor suppressor effects of ANXA7 in hormone-resistant cancer cells of breast versus prostate origin.
Bera A; Leighton XM; Pollard H; Srivastava M
Trends Cancer Res; 2018; 13():55-62. PubMed ID: 30369774
[TBL] [Abstract][Full Text] [Related]
2. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
4. ANXA7 expression represents hormone-relevant tumor suppression in different cancers.
Srivastava M; Torosyan Y; Raffeld M; Eidelman O; Pollard HB; Bubendorf L
Int J Cancer; 2007 Dec; 121(12):2628-36. PubMed ID: 17708571
[TBL] [Abstract][Full Text] [Related]
5. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells.
Torosyan Y; Dobi A; Glasman M; Mezhevaya K; Naga S; Huang W; Paweletz C; Leighton X; Pollard HB; Srivastava M
Oncogene; 2010 Apr; 29(17):2457-66. PubMed ID: 20190808
[TBL] [Abstract][Full Text] [Related]
6. Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.
Srivastava M; Leighton X; Starr J; Eidelman O; Pollard HB
Biomed Res Int; 2014; 2014():193635. PubMed ID: 24864229
[TBL] [Abstract][Full Text] [Related]
7. ANXA7-GTPase as Tumor Suppressor: Mechanisms and Therapeutic Opportunities.
Leighton X; Eidelman O; Jozwik C; Pollard HB; Srivastava M
Methods Mol Biol; 2017; 1513():23-35. PubMed ID: 27807828
[TBL] [Abstract][Full Text] [Related]
8. High ANXA7 Potentiates Eucalyptol Toxicity in Hormone-refractory Prostate Cancer.
Leighton X; Bera A; Eidelman O; Eklund M; Puthillathu N; Pollard HB; Srivastava M
Anticancer Res; 2018 Jul; 38(7):3831-3842. PubMed ID: 29970503
[TBL] [Abstract][Full Text] [Related]
9. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
[TBL] [Abstract][Full Text] [Related]
10. A Dominant-Negative Mutant of ANXA7 Impairs Calcium Signaling and Enhances the Proliferation of Prostate Cancer Cells by Downregulating the IP3 Receptor and the PI3K/mTOR Pathway.
Srivastava M; Bera A; Eidelman O; Tran MB; Jozwik C; Glasman M; Leighton X; Caohuy H; Pollard HB
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240163
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.
Leighton X; Bera A; Eidelman O; Bubendorf L; Zellweger T; Banerjee J; Gelmann EP; Pollard HB; Srivastava M
PLoS One; 2018; 13(10):e0205837. PubMed ID: 30321230
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Cyclin E and its Low Molecular Weight Isoforms Cooperate with Loss of p53 in Promoting Oncogenic Properties of MCF-7 Breast Cancer Cells.
Montazeri H; Bouzari S; Azadmanesh K; Ostad SN; Ghahremani MH
Asian Pac J Cancer Prev; 2015; 16(17):7575-82. PubMed ID: 26625764
[TBL] [Abstract][Full Text] [Related]
13. Potential role of annexin A7 in cancers.
Guo C; Liu S; Greenaway F; Sun MZ
Clin Chim Acta; 2013 Aug; 423():83-9. PubMed ID: 23639634
[TBL] [Abstract][Full Text] [Related]
14. Annexin A7 is correlated with better clinical outcomes of patients with breast cancer.
Huang Y; Wang H; Yang Y
J Cell Biochem; 2018 Sep; 119(9):7577-7584. PubMed ID: 29893423
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
16. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer.
Hsu PI; Huang MS; Chen HC; Hsu PN; Lai TC; Wang JL; Lo GH; Lai KH; Tseng CJ; Hsiao M
J Surg Oncol; 2008 Jun; 97(7):609-14. PubMed ID: 18449914
[TBL] [Abstract][Full Text] [Related]
17. Annexin A7 and Its Related Protein Suppressor of Death Domains Regulates Migration and Proliferation of Hca-P Cells.
Wang S; Bai Q; Yu X; Gao F; Sun Y; Wang X
Cell J; 2023 Nov; 25(11):801-808. PubMed ID: 38071412
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions.
Tanaka A; Kamiakito T; Takayashiki N; Sakurai S; Saito K
Virchows Arch; 2002 Oct; 441(4):380-4. PubMed ID: 12404063
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
Akli S; Zheng PJ; Multani AS; Wingate HF; Pathak S; Zhang N; Tucker SL; Chang S; Keyomarsi K
Cancer Res; 2004 May; 64(9):3198-208. PubMed ID: 15126360
[TBL] [Abstract][Full Text] [Related]
20. Annexin A7 deficiency potentiates cardiac NFAT activity promoting hypertrophic signaling.
Voelkl J; Alesutan I; Pakladok T; Viereck R; Feger M; Mia S; Schönberger T; Noegel AA; Gawaz M; Lang F
Biochem Biophys Res Commun; 2014 Feb; 445(1):244-9. PubMed ID: 24508799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]